Literature DB >> 3921243

Role of polyamines in estradiol-induced growth of human breast cancer cells.

G Lima, R P Shiu.   

Abstract

The present study explored the possible involvement of polyamines in estradiol-stimulated proliferation of human breast cancer cells using the estrogen-responsive subline of T-47D cells (clone 11). 17 beta-Estradiol (10(-10) M) stimulated cell growth 2- to 4-fold. This estradiol-induced proliferation was associated with a peak (at 12-24 h) of activity of ornithine decarboxylase (ODC), the first and rate-limiting enzyme of polyamine biosynthesis. Estradiol-induced cell growth and ODC activity were observed only in the presence of 10% charcoal-treated fetal bovine serum, suggesting that serum factors are required for estrogen action. alpha-Difluoromethylornithine (DFMO, 0.1 mM), a specific inhibitor of ODC, blocked the estradiol-induced cell proliferation and ODC activity. Putrescine (0.1 mM) rescued the inhibitory effect of DFMO on growth of steroid-treated cells. Putrescine alone was not stimulatory to cells, and in combinations with estradiol, it did not augment the effect of estradiol. In addition, DFMO abolished the estradiol-induced growth of several other hormone-responsive cell lines but did not affect the proliferation of unresponsive cells. Hormone-responsive cells exhibited differential sensitivity to DFMO; resistant cell lines (e.g., MCF-7) were found to possess higher endogeneous levels of ODC than sensitive cell lines (e.g., T-47D and ZR-75-1). Our findings indicate that polyamines are essential, although not sufficient, in estrogen stimulation of human breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921243

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Selectivity of polyamine involvement in hormone action on normal and neoplastic target tissues of the rat.

Authors:  A Manni; B Badger; J Lynch; L Demers
Journal:  Breast Cancer Res Treat       Date:  1991 Jan-Feb       Impact factor: 4.872

2.  Kinetic and morphometric responses of heterogeneous populations of NMU-induced rat mammary tumor cells to hormone and antipolyamine therapy in vivo.

Authors:  A Manni; S Lancaster; H English; B Badger; J Lynch; L Demers
Journal:  Breast Cancer Res Treat       Date:  1991 Jan-Feb       Impact factor: 4.872

3.  Beneficial effects of a polyamine biosynthesis inhibitor on lupus in MRL-lpr/lpr mice.

Authors:  T J Thomas; R P Messner
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

4.  Variations in amplification and expression of the ornithine decarboxylase gene in human breast cancer cells.

Authors:  T Thomas; D T Kiang; O A Jänne; T J Thomas
Journal:  Breast Cancer Res Treat       Date:  1991-11       Impact factor: 4.872

5.  Structure-activity relations of S-adenosylmethionine decarboxylase inhibitors on the growth of MCF-7 breast cancer cells.

Authors:  T Thomas; C A Faaland; S Adhikarakunnathu; T J Thomas
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

6.  Effects of female sex hormones on polyamine-oxidizing enzyme activities and polyamine concentrations in immature rat uterus and liver.

Authors:  O Dimitrov; V Pavlov; I Jotova
Journal:  Experientia       Date:  1996-08-15

7.  Polyamine involvement in the secretion and action of TGF-alpha in hormone sensitive human breast cancer cells in culture.

Authors:  I Kim; A Manni; J Lynch; L Demers
Journal:  Breast Cancer Res Treat       Date:  1991-05       Impact factor: 4.872

8.  Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: therapeutic implications.

Authors:  T Thomas; T J Thomas
Journal:  Breast Cancer Res Treat       Date:  1994-02       Impact factor: 4.872

9.  Early estrogen-induced metabolic changes and their inhibition by actinomycin D and cycloheximide in human breast cancer cells: 31P and 13C NMR studies.

Authors:  M Neeman; H Degani
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

10.  Antiproliferative effects of interferon gamma in combination with alpha-difluoromethylornithine on human carcinoma cell cultures.

Authors:  M Klouche; H Kirchner; F Hölzel
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.